Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

US vs The World

How Prenatal Guidance Differs by Region

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

0 human trials, about 3 studies, Narrative review of 43 countries; multinational surveys. The written rationale for this grade is still being prepared.

FDA
Guidance varies by national authority (ACOG, NICE, WHO, EFSA, and others)
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

The practical risk of this fragmentation is confusion. A pregnant person reading international sources, or moving between countries, may meet genuinely conflicting advice, especially on iron and vitamin D. None of these national bodies is simply wrong; they weigh similar evidence against different baseline diets, latitudes, fortification laws, and risk tolerances. The takeaway is not to pick a favorite country's guidance off the internet and self-prescribe, since some nutrients (iron and iodine among them) carry real risks in excess. Anyone weighing conflicting national sources should follow the guidance of the system providing their care and raise the conflict directly with a qualified prenatal provider, who can account for individual diet, labs, and history.

Prenatal nutrition guidance is not a single global standard; it is a patchwork of national authorities that read shared evidence against different diets, latitudes, fortification laws, and health systems. A review of 43 countries found only one true constant: every country recommends folic acid, usually 400 mcg. After that, divergence is the rule. The US (CDC) recommends routine low-dose iron for all pregnant people, while the UK recommends iron only when a woman is iron deficient. On folic acid delivery the split is structural: the US has mandated fortification of grains since 1998, while most of Europe has relied on voluntary fortification and supplement advice. In lower-income settings the frame shifts again, from individual supplements toward WHO population programs, iron-folic acid tablets and, more recently, multiple micronutrient supplements. And on the outcome that matters most, the US records the highest maternal mortality among wealthy nations.

The advice a pregnant person gets depends heavily on where they live, and the differences between the US, Europe, the UK, and the wider world are larger than most people realize.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Understanding why prenatal advice differs across countries
  • Interpreting guidance when relocating or comparing sources from different nations
  • Seeing where the US is more, or less, aggressive than peer countries
  • Recognizing that the recommendation is really many national recommendations
  • Understanding why WHO population programs in lower-income settings look different from individual supplement advice in wealthy ones

What people get wrong

  • Often saidThere is a single, universal set of prenatal supplement recommendations that all doctors follow.

    ActuallyThere is not. Across 43 countries the only near-universal recommendation is folic acid, typically 400 mcg. Iron, vitamin D, and iodine guidance differ widely by country, latitude, diet, and income level, and even wealthy peer nations reach near-opposite routine-iron policies.

  • Often saidUS guidance is the global gold standard everyone else copies.

    ActuallyThe US is one credible system among several. It is more aggressive than the UK on routine iron, it mandates folic acid fortification where most of Europe does not, and its iodine reference value differs from WHO. On the outcome that matters most, maternal mortality, the US records the highest rate among high-income countries per the Commonwealth Fund.

  • Often saidIf a country has not made folic acid fortification mandatory, it must not think folic acid matters.

    ActuallyMost of Europe treats folic acid as essential but delivers it through voluntary fortification and supplement advice rather than a mandate. The stated reasons are practical: concern about masking vitamin B12 deficiency in older adults and the ethics of medicating a whole population to reach one group. The disagreement is about delivery, not about whether folic acid works.

Who profits, and who pushes back

  • 43-country narrative review

    endorsesGeographically diverse comparison (2023)

    Every country recommends folic acid (typically 400 mcg), about half recommend iron (16 to 195 mg), and roughly a quarter recommend vitamin D and iodine; location and income level shape the recommendations.

  • UK NHS / RCOG

    caveatsUnited Kingdom guidance

    Folic acid 400 mcg (5 mg for higher-risk) and vitamin D 10 mcg are advised for all, but routine iron is not recommended unless a woman is deficient, a deliberately more conservative stance than the US.

  • CDC / ACOG

    endorsesUnited States guidance

    A daily prenatal plus universal low-dose iron (CDC, 30 mg) and anemia screening are recommended, a more iron-forward approach than several high-income peers.

  • WHO / EFSA

    mixedGlobal and European reference bodies

    International bodies set their own targets, such as iodine at 200 to 250 mcg, that differ from individual national values, reflecting different populations and assumptions.

Where the research comes from

Most of the published research on this comes from one place. 50% of it is from Recommend routine iron. Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Share of published research by country of origin.
PlaceShare of published research
Recommend routine iron50%
Do not (mostly high-income)50%

Research published from: Global.

How we got here

Prenatal nutrition guidance grew up nationally, not globally. As the science matured through the late twentieth century, health authorities in each country built advice around their own food supply, sunlight, fortification laws, and health-system philosophy, which is why the guidance still diverges. Folic acid became the shared recommendation everywhere because the neural-tube-defect evidence from the early 1990s was overwhelming and hard to argue with. Delivery then split along policy lines: the United States and Canada moved to mandate folic acid in cereal grains in 1998, while much of Europe stayed with voluntary fortification and supplement advice, citing concern about masking vitamin B12 deficiency in older adults and the ethics of medicating a whole population. In parallel, the World Health Organization built guidance aimed at lower-income settings, where the problem is less about choosing among supplements and more about closing wide gaps between nutrient needs and everyday intake. Cross-country reviews in 2017 and 2022 documented how far the recommendations still spread.

  1. 1991-1992UK MRC trial and US Public Health Service guidance establish folic acid as the neural-tube-defect prevention standard, later adopted worldwide
  2. 1998The United States and Canada begin mandatory folic acid fortification of cereal grains; most of Europe keeps voluntary fortification
  3. 2016WHO antenatal care guidance recommends daily iron-folic acid supplements (30 to 60 mg iron plus 400 mcg folic acid), aimed largely at lower-income settings
  4. 2017First data collection for a 43-country review of prenatal supplement recommendations; folic acid is the lone universal item
  5. 2020WHO updates its position on multiple micronutrient supplements, moving from not recommended to recommended in the context of rigorous research
  6. 2022-2023The 43-country review is reevaluated and published; a separate global review counts 69 countries with mandatory folic acid fortification
  7. 2024Commonwealth Fund international brief reports the US maternal mortality rate remains the highest among 14 high-income countries

At a glance

Folic acid
Near-universal (~400 mcg)
Iron (US/CDC)
Routine 30 mg
Iron (UK/NHS)
Only if deficient
Vit D (UK)
10 mcg for all

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about US vs The World. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources